Genetic & Genomic MedicinemedRxivPreprint
Randomised trial of Aureobasidium pullulans-produced beta 1,3-1,6-glucans in patients with Duchenne muscular dystrophy: Favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Naoki Yamamoto…·Samuel JK Abraham
A pilot study examines the effects of Aureobasidium pullulans-produced beta 1,3-1,6-glucans on gut microbiota and clinical outcomes in Duchenne muscular dystrophy patients, showing beneficial microbiome changes and anti-inflammatory effects.
11 citations